Products and withdrawal from the market Sibutramine was approved in 1999 and was commercially available in many countries in 10- and 15-mg capsule form (Reductil, Abbott AG). On March 29, 2010, Abbott AG, in consultation with Swissmedic, informed the public that the marketing authorization had been suspended. Since then, sibutramine may no longer be prescribed … Sibutramine
Products Rosiglitazone was commercially available in tablet form (Avandia). It had been approved since 1999 and was also commercially available in fixed combination with the biguanide metformin (Avandamet). The combination with the sulfonylurea glimepiride (Avaglim, EU, off-label) was not approved in many countries. A publication in on possible cardiovascular risks led to a controversy about … Rosiglitazone
When it comes to administering medication, children are still often treated like small adults; suitable pills for the little ones hardly exist. That is to change soon. Since the end of January, the new EU regulation on medicines for children has already been in force, which is intended to ensure greater safety for children. It … Medications for Children: Medications Must Also Be Adapted to Children
Experience shows that implementation in practice will only take place gradually. But for consumers and physicians alike, the new regulation has a very practical help in store: medicines that have been specifically approved for use in children and adolescents will in future bear a special identification symbol on the packaging. The imprint on the package … Medicines for Children: Symbols on the Packaging
